{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:23:45Z","timestamp":1790936625707,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T00:00:00Z","timestamp":1101340800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00213-004-2049-6","type":"journal-article","created":{"date-parts":[[2004,11,24]],"date-time":"2004-11-24T13:14:48Z","timestamp":1101302088000},"page":"489-497","source":"Crossref","is-referenced-by-count":27,"title":["Quantitative analysis of the effects of some ?atypical? and ?conventional? antipsychotics on progressive ratio schedule performance"],"prefix":"10.1007","volume":"179","author":[{"given":"Z.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Rickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Body","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Szabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,11,25]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0091-3057(98)00112-9","volume":"61","author":"JE Aberman","year":"1998","unstructured":"Aberman JE, Ward SJ, Salamone JD (1998) Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance. Pharmacol Biochem Behav 61:341?348","journal-title":"Pharmacol Biochem Behav"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0091-3057(96)00445-5","volume":"57","author":"J Arnold","year":"1997","unstructured":"Arnold J, Roberts DCS (1997) A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav 57:441?447","journal-title":"Pharmacol Biochem Behav"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/026988110101500108","volume":"15","author":"RA Bantick","year":"2001","unstructured":"Bantick RA, Deakin JFW, Grasby PM (2001) The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? J Psychopharmacol 15:37?46","journal-title":"J Psychopharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130050812","volume":"141","author":"AM Barr","year":"1998","unstructured":"Barr AM, Philips AG (1998) Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement. Psychopharmacology 141:99?106","journal-title":"Psychopharmacology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1037\/0097-7403.23.3.351","volume":"23","author":"LA Bizo","year":"1997","unstructured":"Bizo LA, Killeen PR (1997) Models of ratio schedule performance. J Exp Psychol [Anim Behav Proc] 23:351?367","journal-title":"J Exp Psychol [Anim Behav Proc]"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF02246039","volume":"104","author":"M Cador","year":"1991","unstructured":"Cador M, Taylor JR, Robbins TW (1991) Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens. Psychopharmacology 104:377?385","journal-title":"Psychopharmacology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00008877-199503000-00004","volume":"6","author":"S Cheeta","year":"1995","unstructured":"Cheeta S, Brooks S, Willner P (1995) Effects of reinforcer sweetness and the D2\/D3 antagonist raclopride on progressive ratio operant responding. Behav Pharmacol 6:127?132","journal-title":"Behav Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002130100682","volume":"155","author":"J Cilia","year":"2001","unstructured":"Cilia J, Piper DC, Upton N, Hagan JJ (2001) Clozapine enhances breakpoint in common marmosets responding on a progressive ratio schedule. Psychopharmacology 155:135?143","journal-title":"Psychopharmacology"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0920-9964(02)00379-1","volume":"63","author":"PW Corrigan","year":"2003","unstructured":"Corrigan PW, Reinke RR, Landsberger SA, Charate A, Toombs GA (2003) The effects of atypical antipsychotic medications on psychosocial outcomes. Schizophr Res 63:97?101","journal-title":"Schizophr Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0028-3908(01)00022-3","volume":"40","author":"A Dekeyne","year":"2001","unstructured":"Dekeyne A, Rivet J-M, Gobert A, Millan MJ (2001) Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT. Neuropharmacology 40:899?910","journal-title":"Neuropharmacology"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s002130050426","volume":"134","author":"PJ Fletcher","year":"1997","unstructured":"Fletcher PJ, Higgins GA (1997) Differential effects of ondansetron and ?-flupenthixol on responding for conditioned reward. Psychopharmacology 134:64?72","journal-title":"Psychopharmacology"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2165\/00003495-200262080-00015","volume":"62","author":"NS Gunasekara","year":"2002","unstructured":"Gunasekara NS, Spencer CM, Keating GM (2002) Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder. Drugs 62:1217?1251","journal-title":"Drugs"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0091-3057(99)00092-1","volume":"64","author":"S Hamill","year":"1999","unstructured":"Hamill S, Trevitt JT, Nowend KL, Carlson BB, Salamone JD (1999) Nucleus accumbens dopamine depletion and time-constrained progressive ratio performance: effects of different ratio requirements. Pharmacol Biochem Behav 64:21?27","journal-title":"Pharmacol Biochem Behav"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1901\/jeab.1983.40-113","volume":"40","author":"GM Heyman","year":"1983","unstructured":"Heyman GM (1983) A parametric evaluation of the hedonic and motoric effects of drugs: pimozide and amphetamine. J Exp Anal Behav 40:113?122","journal-title":"J Exp Anal Behav"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-002-1375-9","volume":"167","author":"M-Y Ho","year":"2003","unstructured":"Ho M-Y, Body S, Kheramin S, Bradshaw CM, Szabadi E (2003) Effects of 8-OH-DPAT and WAY-100635 on performance on a time-constrained progressive-ratio schedule. Psychopharmacology 167:137?144","journal-title":"Psychopharmacology"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.134.3483.943","volume":"134","author":"W Hodos","year":"1961","unstructured":"Hodos W (1961) Progressive ratio as a measure of reward strength. Science 134:943?944","journal-title":"Science"},{"key":"CR17","first-page":"389","volume":"6","author":"W Hodos","year":"1963","unstructured":"Hodos W, Kalman G (1963) Effects of increment size and reinforcer volume on progressive ratio performance. J Exp Anal Behav 6:389?392","journal-title":"J Exp Anal Behav"},{"issue":"Suppl 1","key":"CR18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-2000-7660","volume":"33","author":"J Horacek","year":"2000","unstructured":"Horacek J (2000) Novel antipsychotics and extrapyramidal side effects. Theory and reality. Pharmacopsychiatry 33(Suppl 1):34?42","journal-title":"Pharmacopsychiatry"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","volume":"76","author":"J Ichikawa","year":"2001","unstructured":"Ichikawa J, Ishii H, Bonaccorsco S, Fowler WL, O?Laughlin IA, Meltzer HY (2001) 5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76:1521?1531","journal-title":"J Neurochem"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","volume":"441","author":"S Jordan","year":"2002","unstructured":"Jordan S, Koprivica V, Chen R, Tottori K, Kikuchi T, Altar CA (2002) The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur J Pharmacol 441:137?140","journal-title":"Eur J Pharmacol"},{"key":"CR21","first-page":"implications","volume":"schedule","author":"Kheramin","year":"2004","unstructured":"Kheramin S, Body S, Miranda Herrera F, Bradshaw CM, Szabadi E, Deakin JFW, Anderson IM (2004) The effect of orbital prefrontal cortex lesions on performance on a progressive ratio schedule: implications for models of inter-temporal choice. Behav Brain Res (in press)","journal-title":"The effect of orbital prefrontal cortex lesions on performance on a progressive ratio"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S0140525X00033628","volume":"17","author":"PR Killeen","year":"1994","unstructured":"Killeen PR (1994) Mathematical principles of reinforcement. Behav Brain Sci 17:105?172","journal-title":"Behav Brain Sci"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0376-6357(03)00017-2","volume":"62","author":"PR Killeen","year":"2003","unstructured":"Killeen PR, Sitomer MT (2003) MPR. Behav Proc 62:49?64","journal-title":"Behav Proc"},{"key":"CR25","unstructured":"King DJ, Waddington JL (2004) Antipsychotic drugs and the treatment of schizophrenia. In: King DJ (ed) Seminars in psychopharmacology, 2nd edn. Gaskell, London (in press)"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0091-3057(92)90156-A","volume":"42","author":"EA Loh","year":"1992","unstructured":"Loh EA, Fitch T, Vickers G, Roberts DCS (1992) Clozapine increases breaking points on a progressive-ratio schedule reinforced by intravenous cocaine. Pharmacol Biochem Behav 42:559?562","journal-title":"Pharmacol Biochem Behav"},{"key":"CR27","first-page":"238","volume":"251","author":"H Meltzer","year":"1989","unstructured":"Meltzer H, Matsubara S, Lee J-C (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin-2 pKi values. J Pharmacol Exp Ther 251:238?246","journal-title":"J Pharmacol Exp Ther"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s002130000486","volume":"152","author":"S Mobini","year":"2000","unstructured":"Mobini S, Chiang T-J, Ho M-Y, Bradshaw CM, Szabadi E (2000) Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat. Psychopharmacology 152:47?54","journal-title":"Psychopharmacology"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF00431461","volume":"84","author":"MJ Morley","year":"1984","unstructured":"Morley MJ, Bradshaw CM, Szabadi E (1984) The effects of pimozide on variable-interval performance: a test of the ?anhedonia? hypothesis of the mode of action of neuroleptic drugs. Psychopharmacology 84:531?536","journal-title":"Psychopharmacology"},{"issue":"Suppl 4","key":"CR30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0924-9338(03)00077-4","volume":"17","author":"F M\u00fcller-Spahn","year":"2002","unstructured":"M\u00fcller-Spahn F (2002) Current use of atypical antipsychotics. Eur Psychiatry 17(Suppl 4):377?384","journal-title":"Eur Psychiatry"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0014-2999(98)00483-X","volume":"355","author":"A Newman-Tancredi","year":"1998","unstructured":"Newman-Tancredi A, Gavaudan S, Conte C, Chaput C, Touzard M, Verriele L, Audinot V, Millan MJ (1998) Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTP S binding study. Eur J Pharmacol 355:245?256","journal-title":"Eur J Pharmacol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(05)63079-6","volume":"350","author":"LS Pilowsky","year":"1997","unstructured":"Pilowsky LS, Mulligan RS, Acton PD, Ell PJ, Costa DC, Kerwin RW (1997) Limbic selectivity of clozapine. Lancet 350:490?491","journal-title":"Lancet"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0376-6357(03)00027-5","volume":"62","author":"MP Reilly","year":"2003","unstructured":"Reilly MP (2003) Extending mathematical principles of reinforcement into the domain of behavioral pharmacology. Behav Proc 62:75?88","journal-title":"Behav Proc"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1385\/0-89603-217-5:233","volume-title":"Neuromethods., vol 24: animal models of drug addiction","author":"DCS Roberts","year":"1992","unstructured":"Roberts DCS, Richardson NR (1992) Self-administration of psychostimulants using progressive ratio schedules of reinforcement. In: Boulton A, Baker G, Wu PH (eds) Neuromethods., vol 24: animal models of drug addiction. Humana, New York, pp 233?269"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-3223(00)00850-7","volume":"48","author":"H Rollema","year":"2000","unstructured":"Rollema H, Lu Y, Schmidt AW, Sprouse JS, Zorn SH (2000) 5-HT1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex. Biol Psychiatry 48:229?237","journal-title":"Biol Psychiatry"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130000610","volume":"153","author":"JK Rowlett","year":"2000","unstructured":"Rowlett JK (2000) A labor-supply analysis of cocaine self-administration under progressive ratio schedules: antecedents, methodologies, and perspectives. Psychopharmacology 153:1?16","journal-title":"Psychopharmacology"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF00310507","volume":"88","author":"JD Salamone","year":"1986","unstructured":"Salamone JD (1986) Different effects of haloperidol and extinction on instrumental behaviors. Psychopharmacology 88:18?23","journal-title":"Psychopharmacology"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/978-1-4613-1819-4_10","volume-title":"Handbook of psychopharmacology","author":"JD Salamone","year":"1987","unstructured":"Salamone JD (1987) The actions of neuroleptic drugs on appetitive instrumental behaviors. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology. Plenum, New York, pp 575?608"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0166-4328(94)90108-2","volume":"65","author":"JD Salamone","year":"1994","unstructured":"Salamone JD, Cousins MS, Butcher S (1994) Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletionon instrumental response selection in a T-maze cost\/benefit procedure. Behav Brain Res 65:221?229","journal-title":"Behav Brain Res"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0149-7634(96)00017-6","volume":"21","author":"JD Salamone","year":"1997","unstructured":"Salamone JD, Cousins MS, Snyder BJ (1997) Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev 21:341?359","journal-title":"Neurosci Biobehav Rev"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","volume":"425","author":"AW Schmidt","year":"2001","unstructured":"Schmidt AW, Lebel LA, Howard HR, Zorn SH (2001) Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 425:197?201","journal-title":"Eur J Pharmacol"},{"key":"CR42","first-page":"261","volume":"7","author":"P Seeman","year":"1992","unstructured":"Seeman P (1992) Dopamine receptor sequences: therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7:261?284","journal-title":"Neuropsychopharmacology"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0893-133X(96)00187-X","volume":"16","author":"P Seeman","year":"1997","unstructured":"Seeman P, Corbett R, van Tol HHM (1997) Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology 16:93?110","journal-title":"Neuropsychopharmacology"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/lmot.1993.1019","volume":"24","author":"P Skjoldager","year":"1993","unstructured":"Skjoldager P, Pierre PJ, Mittleman G (1993) Reinforcer magnitude and progressive ratio responding in the rat: effects of increased effort, prefeeding, and extinction. Learn Motiv 24:303?343","journal-title":"Learn Motiv"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002130050702","volume":"139","author":"D Stafford","year":"1998","unstructured":"Stafford D, LeSage MG, Glowa JR (1998) Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology 139:169?184","journal-title":"Psychopharmacology"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/00049537508255235","volume":"27","author":"WJ Stewart","year":"1975","unstructured":"Stewart WJ (1975) Progressive ratio reinforcement schedules: a review and evaluation. Aust J Psychol 27:9?22","journal-title":"Aust J Psychol"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S0140525X00010372","volume":"5","author":"RA Wise","year":"1982","unstructured":"Wise RA (1982) Neuroleptics and operant behavior: the anhedonia hypothesis. Brain Behav Sci 5:39?87","journal-title":"Brain Behav Sci"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.ps.40.020189.001203","volume":"40","author":"RA Wise","year":"1989","unstructured":"Wise RA, Rompre P-P (1989) Brain dopamine and reward. Annu Rev Psychol 40:191?225","journal-title":"Annu Rev Psychol"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.566469","volume":"201","author":"RA Wise","year":"1978","unstructured":"Wise RA, Spindler J, de Wit H, Gerber GJ (1978) Neurolepti-induced ?anhedonia? in rats: pimozide blocks the reward quality of food. Science 201:262?264","journal-title":"Science"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-2049-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-004-2049-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-2049-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:01:22Z","timestamp":1558627282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-004-2049-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,25]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["2049"],"URL":"https:\/\/doi.org\/10.1007\/s00213-004-2049-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,25]]}}}